Mycobacterium tuberculosis - Infectious Diseases

What is Mycobacterium Tuberculosis?

Mycobacterium tuberculosis (MTB) is the bacterium responsible for causing tuberculosis (TB), a serious infectious disease that primarily affects the lungs but can also affect other parts of the body. It is an aerobic, non-motile, rod-shaped bacterium that is part of the genus Mycobacterium.

How is it Transmitted?

MTB is primarily transmitted via airborne droplets when an infected person coughs, sneezes, or talks. These droplets can be inhaled by individuals nearby, leading to infection. Close and prolonged contact with an infected person increases the risk of transmission.

What are the Symptoms?

The symptoms of TB can be systemic or localized. Common systemic symptoms include prolonged fever, night sweats, and weight loss. Pulmonary TB, the most common form, often manifests as a persistent cough, chest pain, and the production of sputum, which may be blood-tinged.

Diagnosis

Diagnosing TB involves a combination of clinical evaluation, radiological findings, and microbiological tests. The Mantoux tuberculin skin test and the Interferon-Gamma Release Assays (IGRAs) are commonly used immunological tests. Microbiological diagnosis typically involves sputum smear microscopy, culture, and molecular tests like PCR.

Treatment

TB treatment usually involves a prolonged course of multiple antibiotics. The standard regimen includes isoniazid, rifampicin, ethambutol, and pyrazinamide for an initial two-month phase, followed by isoniazid and rifampicin for an additional four months. Treatment adherence is critical to prevent antibiotic resistance.

Drug-Resistant TB

Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) pose significant challenges in treatment. MDR-TB is resistant to at least isoniazid and rifampicin, while XDR-TB is resistant to these first-line drugs and additional second-line drugs. Treatment of drug-resistant TB often requires more toxic and less effective medications for a longer duration.

Prevention

Prevention strategies include vaccination with the BCG vaccine, which provides partial protection against TB. Public health measures such as isolation of infectious patients, proper ventilation, and the use of personal protective equipment are also crucial in preventing the spread of the disease.

Global Impact

TB remains a significant global health issue, with millions of new cases and deaths each year. It is most prevalent in low- and middle-income countries with high rates of HIV/AIDS, as HIV co-infection significantly increases the risk of developing active TB.

Conclusion

Mycobacterium tuberculosis is a formidable pathogen with significant public health implications. Effective control and eventual eradication of TB require a combination of early diagnosis, effective treatment, and robust preventive measures.



Relevant Publications